Inhibition of mTOR is the standard of care for lymphangioleiomy-omatosis (LAM). However, this therapy has variable tolerability andsome patients show progressive decline of lung function despitetreatment. LAM diagnosis and monitoring can also be challengingdue to the heterogeneity of symptoms and insufficiency of non-invasive tests. Here, we propose monoamine-derived biomarkersthat provide preclinical evidence for novel therapeutic approaches.The major histamine-derived metabolite methylimidazoleaceticacid (MIAA) is relatively more abundant in LAM plasma, and MIAAvalues are independent of VEGF-D. Higher levels of histamine areassociated with poorer lung function and greater disease burden.Molecular and cellular analyses, and metabolic profiling confirmedactive histamine signaling and metabolism. LAM tumorigenesis isreduced using approved drugs targeting monoamine oxidases A/B(clorgyline and rasagiline) or histamine H1 receptor (loratadine),and loratadine synergizes with rapamycin. Depletion of Maoa orHrh1 expression, and administration of an L-histidine analog, or alow L-histidine diet, also reduce LAM tumorigenesis. These findingsextend our knowledge of LAM biology and suggest possible ways ofimproving disease management.

Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

Concettina La Motta;
2021-01-01

Abstract

Inhibition of mTOR is the standard of care for lymphangioleiomy-omatosis (LAM). However, this therapy has variable tolerability andsome patients show progressive decline of lung function despitetreatment. LAM diagnosis and monitoring can also be challengingdue to the heterogeneity of symptoms and insufficiency of non-invasive tests. Here, we propose monoamine-derived biomarkersthat provide preclinical evidence for novel therapeutic approaches.The major histamine-derived metabolite methylimidazoleaceticacid (MIAA) is relatively more abundant in LAM plasma, and MIAAvalues are independent of VEGF-D. Higher levels of histamine areassociated with poorer lung function and greater disease burden.Molecular and cellular analyses, and metabolic profiling confirmedactive histamine signaling and metabolism. LAM tumorigenesis isreduced using approved drugs targeting monoamine oxidases A/B(clorgyline and rasagiline) or histamine H1 receptor (loratadine),and loratadine synergizes with rapamycin. Depletion of Maoa orHrh1 expression, and administration of an L-histidine analog, or alow L-histidine diet, also reduce LAM tumorigenesis. These findingsextend our knowledge of LAM biology and suggest possible ways ofimproving disease management.
2021
Herranz, Carmen; Mateo, Francesca; Baiges, Alexandra; Ruiz de Garibay, Gorka; Junza, Alexandra; R Johnson, Simon; Miller, Suzanne; Garcıa, Nadia; Capellades, Jordi; Gomez, Antonio; Vidal, August; Palomero, Luis; Espın, Roderic; I Extremera, Ana; Blommaert, Eline; Revilla-Lopez, Eva; Saez, Berta; Gomez-Olles, Susana; Ancochea, Julio; Valenzuela, Claudia; Alonso, Tamara; Ussetti, Piedad; Laporta, Rosalıa; Xaubet, Antoni; A Rodrıguez-Portal, Jose; Montes-Worboys, Ana; Machahua, Carlos; Bordas, Jaume; A Menendez, Javier; M Cruzado, Josep; Guiteras, Roser; Bontoux, Christophe; LA MOTTA, Concettina; Noguera-Castells, Aleix; Mancino, Mario; Lastra, Enrique; Rigo-Bonnin, Raul; C Perales, Jose; Vinals, Francesc; Lahiguera, Alvaro; Zhang, Xiaohu; Cuadras, Daniel; M van Moorsel, Coline H; J van der Vis, Joanne; R Quanjel, Marian J; Filippakis, Harilaos; Hakem, Razq; Gorrini, Chiara; Ferrer, Marc; Ugun-Klusek, Aslihan; Billett, Ellen; Radzikowska, Elzbieta; Casanova, Alvaro; Molina-Molina, Marıa; Roman, Antonio; Yanes, Oscar; Pujana., Miquel A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1106212
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact